Health Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation November 16, 2024
Health Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas–Inherited Gastrointestinal Cancers November 15, 2024
Health Foresee Pharmaceuticals Receives the Second Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty November 15, 2024
Health International Cancer Organizations Present Collaborative Work During Oncology Event in China November 15, 2024
Health Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 November 15, 2024
Health FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment November 14, 2024
Search
Health
November 16, 2024
November 15, 2024
November 15, 2024
November 15, 2024
November 15, 2024
November 15, 2024
November 15, 2024
November 15, 2024
November 14, 2024
November 14, 2024
